This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Thomas Wehrman: Innovator in Receptor Tyrosine Kinase Assays
Introduction
Thomas Wehrman is a notable inventor based in the United States. He has made significant contributions to the field of biochemistry, particularly in the area of receptor tyrosine kinases (RTKs). His innovative methods for detecting phosphorylation of RTKs have the potential to advance research in cellular signaling and cancer biology.
Latest Patents
Thomas Wehrman currently holds no patents. However, his work on receptor tyrosine kinase assays is noteworthy. The method he developed employs cells that contain two fusion products: an RTK fused to a small fragment of β-galactosidase and a phosphotyrosine binding peptide fused to the large fragment of β-galactosidase. This innovative approach allows for the detection of phosphorylation events, which are crucial for understanding RTK activation.
Career Highlights
Thomas Wehrman is associated with Eurofins Discoverx Corporation, where he continues to contribute to advancements in biochemical assays. His expertise in receptor tyrosine kinases has positioned him as a valuable asset in the field of drug discovery and development.
Collaborations
Some of his notable coworkers include Wei Feng and William Raab. Their collaborative efforts enhance the research environment and foster innovation within their projects.
Conclusion
Thomas Wehrman's work in receptor tyrosine kinase assays exemplifies the importance of innovation in scientific research. His contributions, although not yet patented, hold promise for future advancements in understanding cellular mechanisms.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile